From Pathway to Decision: Connecting Target Biology to Clinical Outcomes with Mechanistic QSP
Short description: This poster demonstrates how Certara’s Applied BioSimulation team develops mechanistic QSP models that link receptor signaling to cellular and clinical outcomes. The same approach can help de-risk target selection, strengthen dose rationale, and inform biomarker strategies across immunology and other therapeutic areas.
